Navigation Links
More Fake Avastin Found in U.S., FDA Says

WEDNESDAY, April 4 (HealthDay News) -- The U.S. Food and Drug Administration says it has confirmed another counterfeit version of the cancer drug bevacizumab, most commonly known as Avastin, is being sold in the United States.

This time, the counterfeit product -- which the FDA says contains no active ingredient -- is posing as injectable Altuzan (bevacizumab) 400 mg/16ml, a Roche cancer medication that is approved for use in Turkey but not in the United States.

"Packaging or vials found in the U.S. that claim to be Roche's Altuzan with lot number B6021 should be considered counterfeit," the FDA said in a statement released Wednesday.

According to the FDA, medical practices got the fake Altuzan from "foreign sources" that include Richards Pharma (aka Richards Services), Warwick Healthcare Solutions or Ban Dune Marketing Inc (BDMI).

"Many, if not all of the products sold and distributed through this distributor have not been approved by the FDA," the agency said. The agency is urging all medical practices that believe they have received unapproved products from the three companies to "stop using [the products] and contact the FDA."

This is not the first time counterfeit Avastin has been spotted in the United States. In mid-February, Roche's Genetech unit warned of fake vials of Avastin. Later that month, the company said the fake drug was probably not harmful, but did not contain any active ingredient and so would be useless for people fighting cancer.

Doctors infuse Avastin to treat colon, lung, kidney and brain cancer.

According to the Associated Press, worldwide reports of drug counterfeiting have increased over the past 10 years.

More information

There's more on bevacizumab at the U.S. National Cancer Institute.

-- E.J. Mundell

SOURCES: U.S. Food and Drug Administration, news release, April 4, 2012; Associated Press

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Avastin Largely Safe for Patients With Type of Advanced Lung Cancer
2. FDA Advisers Say Avastin Shouldnt Be Used for Breast Cancer
3. FDA Advises Against Avastin as Treatment for Breast Cancer
4. More Evidence Links Avastin to Heart Failure in Breast Cancer Patients
5. More Evidence Cancer Drug Avastin May Cause Harm
6. NIH study finds Avastin and Lucentis are equally effective in treating AMD
7. Cancer Drug Avastin Makes Inroads Against Ovarian Tumors
8. FDA Panel Rejects Avastin for Breast Cancer
9. Avastin Rejection Supported by Cancer Experts
10. Clinical trial shows benefit to adding avastin to neoadjuvant chemotherapy in breast cancer patients
11. FDA Revokes Approval of Avastin for Breast Cancer
Post Your Comments:
Related Image:
More Fake  Avastin Found in U.S., FDA Says
(Date:6/27/2016)... ... June 27, 2016 , ... The ... OSHA Training Institute Education Center headquartered in Northern California, has issued an important ... heat at their worksites. Employers with workers exposed to high temperatures should ...
(Date:6/27/2016)... ... ... "FCPX editors can now reveal their media with growing colorful split screen ... - CEO of Pixel Film Studios. , ProSlice Color brings the split screens ... reveal the media of their split screens with growing colorful panels. , ProSlice Color ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... today its affiliation with Tennessee Counseling Association. This new relationship allows ... the Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... industry today announced its strategic partnership with Connance, a healthcare industry leader ... two companies’ proven, proprietary technology combine to provide health systems, hospitals and ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Global MEMS Devices Medical Market Analysis 2016 - Forecast to ... The report contains up to date financial ... reliable analysis. Assessment of major trends with potential impact on ... dive analysis of market segmentation which comprises of sub markets, ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
(Date:6/23/2016)... 2016  Guerbet announced today that it has been ... Award . One of 12 suppliers to ... its support of Premier members through exceptional local customer ... commitment to lower costs. ... our outstanding customer service from Premier," says Massimo ...
Breaking Medicine Technology: